The H1N1 virus’s rapid spread worldwide last year exposed the weaknesses in the global system for swiftly developing, manufacturing and distributing vaccines for newly identified strains of influenza. In Texas, researchers are attacking the first two of these problems through Project GreenVax , which will use a plant-based approach to vaccine development and a modular manufacturing environment that can scale quickly as vaccine demand grows. [More]
Could Mini Labs and Plant-Based Vaccines Stop the Next Pandemic?
Did this article help you?
If you found this piece useful, please consider supporting our work with a small, one-time or monthly donation. Your contribution enables us to continue bringing you accurate, thought-provoking science and medical news that you can trust. Independent reporting takes time, effort, and resources, and your support makes it possible for us to keep exploring the stories that matter to you. Together, we can ensure that important discoveries and developments reach the people who need them most.